More Children are Developing Cancer, But Fewer are Dying from It

Last month, the American Cancer Society (ACS) released “Cancer Statistics, 2014,” their annual estimate of new cancers diagnoses and deaths for the year ahead. The report was heavily focused on adult malignancies—not surprisingly, given that the number of adult cancer patients in the nation is orders of magnitudes greater than that of childhood patients—but did hold a … Read more

Cancer Immunology at Dana-Farber

Immunotherapy – stimulating the body’s defenses to recognize and destroy disease-causing cells and proteins – was dubbed the “breakthrough of the year” in 2013 by Science magazine. Dana-Farber researchers have contributed many important discoveries over the years about how the immune system works. Now, they are building on these insights to develop immunotherapy against tumors … Read more

New Strategies in Treating Kidney Cancer

Though quite curable when diagnosed early, kidney cancer in advanced stages can become a stubborn disease. However, the outlook for patients with metastatic kidney cancer has brightened in the past several years. Oncologists have added to their arsenal a number of designer drugs that attack molecular targets – genetic abnormalities that drive tumors – with … Read more

Ask the Expert: Questions and Answers about Brain Tumors

Dana-Farber Cancer Institute recently partnered with CancerConnect and Lakshmi Nayak, MD, to answer questions about brain cancer. Nayak is a neuro-oncologist in the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center and an instructor in neurology at Harvard Medical School.  Q: There seems to be some progress concerning treatment of brain tumors, especially immunotherapy. … Read more

Improving Care for Brain Tumor Patients

Highly malignant brain tumors called glioblastomas are the most common primary cancer of the brain; about 11,000 cases are diagnosed every year in the United States. Patrick Y. Wen, MD (Director) and David Reardon, MD, (Medical Director) of the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center describe the efforts to improve care for … Read more

Are Tanning Beds Safe?

Updated 1/28/16 If you’re thinking about hitting the tanning beds to get started on your “base tan,” don’t. That’s the advice of Jennifer Y Lin, MD, of Dana-Farber’s Center for Melanoma Oncology. Melanoma, the most deadly form of skin cancer, is on the rise, particularly in women aged 25-32. The frequency of tanning and age at … Read more

Turning Traditional Medicine Into Cancer Drugs

Quite a few substances used in traditional medicine in China or other countries have received Food and Drug Administration (FDA) approval as cancer drugs… and their numbers are growing.  Some examples are: Arsenic trioxide, made from arsenic sulfide ore, has been used therapeutically for more than 2,400 years. Following promising reports from China, the agent … Read more

Zeroing In On Dark Matter

If the human genome – the complete set of  DNA blueprints in a cell for building a human being — is truly “the book of life, ”  as it has been called, then 99 percent of life’s book is gobbledygook. Only 1 percent of the DNA contains genetic instructions for making the body’s proteins; most … Read more

How to protect children from the sun

Applying sunscreen to wiggly young children can be a challenge, but sun protection is especially critical for young skin. Babies and young children are especially sensitive to the sun. There are several lines of evidence indicating that burns during youth significantly contribute to melanoma risk. For instance, just one blistering sunburn in childhood more than doubles … Read more